Covered recipient · General Payments record
BRADLEY M BLOCK
Allopathic & Osteopathic Physicians Family Medicine
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2020 · Entire year
$3,246.75
19 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2020 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,925.00 | 2 |
| Food and Beverage | $320.75 | 16 |
| Education | $1.00 | 1 |
By paying entity
PY2020 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $2,937.81 | 4 |
| Medtronic Vascular, Inc. | $83.63 | 1 |
| AstraZeneca Pharmaceuticals LP | $60.25 | 4 |
| GlaxoSmithKline, LLC. | $35.96 | 2 |
| Amneal Pharmaceuticals LLC | $21.90 | 1 |
| IBSA Pharma Inc. | $20.19 | 1 |
| Genentech USA, Inc. | $17.48 | 1 |
| Eisai Inc. | $16.84 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.58 | 1 |
| Merck Sharp & Dohme Corporation | $14.52 | 1 |
| Ethicon US, LLC | $12.03 | 1 |
| Novo Nordisk Inc | $11.56 | 1 |
Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
BRADLEY M BLOCK
NPI 1205819307 · CMS profile ID 191172
Allopathic & Osteopathic Physicians / Family Medicine
OVIEDO, FL
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1205819307?year=2020&recipient=provider#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- BRADLEY M BLOCK, NPI 1205819307, CMS profile ID 191172. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1205819307?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
- APA 7
- IndustryPayments. (2026). BRADLEY M BLOCK, NPI 1205819307, CMS profile ID 191172. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1205819307?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
- Bluebook
- BRADLEY M BLOCK, NPI 1205819307, CMS profile ID 191172, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1205819307?year=2020&recipient=provider#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2020
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30
19 matching records · $3,246.75 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 1–19 of 19.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Lilly USA, LLC | $11.81 | 12/02/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 728376999 | CMS |
| Merck Sharp & Dohme Corporation | $14.52 | 10/21/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 747781859 | CMS |
| AstraZeneca Pharmaceuticals LP | $11.67 | 09/30/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 736230833 | CMS |
| GlaxoSmithKline, LLC. | $17.16 | 09/16/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 738477399 | CMS |
| Eisai Inc. | $16.84 | 09/01/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 751257653 | CMS |
| Lilly USA, LLC | $975.00 | 08/20/2020 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 728373457 | CMS |
| Amneal Pharmaceuticals LLC | $21.90 | 08/12/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 719979677 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.58 | 07/31/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 737493815 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.93 | 06/29/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 735779533 | CMS |
| Novo Nordisk Inc | $11.56 | 06/24/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 745024661 | CMS |
| Lilly USA, LLC | $1,950.00 | 06/23/2020 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 728370021 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.65 | 05/19/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 736356689 | CMS |
| IBSA Pharma Inc. | $20.19 | 04/15/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 719680285 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.00 | 04/13/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 735822021 | CMS |
| Lilly USA, LLC | $1.00 | 03/13/2020 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 728356347 | CMS |
| Ethicon US, LLC | $12.03 | 02/26/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 718887809 | CMS |
| Genentech USA, Inc. | $17.48 | 02/12/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 742990153 | CMS |
| Medtronic Vascular, Inc. | $83.63 | 02/10/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 740917211 | CMS |
| GlaxoSmithKline, LLC. | $18.80 | 01/15/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 738656435 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $463,347.97 | 19 |
| PY2024 | Recipient | $32,803.00 | 1 |
| PY2024 | Principal investigator | $565,590.10 | 69 |
| PY2023 | Recipient | $285.00 | 1 |
| PY2023 | Principal investigator | $529,627.42 | 655 |
| PY2022 | Recipient | $610.00 | 1 |
| PY2022 | Principal investigator | $122,619.06 | 206 |
| PY2021 | Recipient | $396.44 | 1 |
| PY2021 | Principal investigator | $386,856.51 | 126 |
| PY2020 | Recipient | $2,077.00 | 3 |
| PY2020 | Principal investigator | $684,365.10 | 151 |
| PY2019 | Recipient | $1,843.74 | 2 |
| PY2019 | Principal investigator | $278,906.72 | 78 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2020
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
154 records in PY2020
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Novo Nordisk AS | $3,548.83 | 12/22/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353843 |
| Principal investigator 1 | Novo Nordisk AS | $200.00 | 12/22/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353845 |
| Principal investigator 1 | Novo Nordisk AS | $63.00 | 12/18/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 822171757 |
| Principal investigator 1 | Novo Nordisk AS | $9,080.49 | 11/30/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353841 |
| Principal investigator 1 | Novo Nordisk AS | $6,559.91 | 10/29/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353725 |
| Principal investigator 1 | Novo Nordisk AS | $24.99 | 10/22/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353719 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353731 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353733 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353735 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353737 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353739 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353741 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353743 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353745 |
| Principal investigator 1 | Novo Nordisk AS | $15.60 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353747 |
| Principal investigator 1 | Novo Nordisk AS | $23.70 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353749 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353751 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353753 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353755 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353757 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353759 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353761 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353763 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353765 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353767 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353769 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353771 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353773 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353775 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353777 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353779 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353781 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353783 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353785 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353787 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353789 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353791 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353793 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353795 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353797 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353799 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353801 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353803 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353805 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353807 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353809 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353811 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353813 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353815 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353817 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353819 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353821 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353823 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353825 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353827 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353829 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353831 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353833 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353835 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353837 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 10/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353839 |
| Principal investigator 1 | Novo Nordisk AS | $5,622.79 | 09/24/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353723 |
| Principal investigator 1 | Novo Nordisk AS | $24.99 | 09/23/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353727 |
| Principal investigator 1 | Novo Nordisk AS | $24.99 | 09/23/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353729 |
| Principal investigator 1 | Novo Nordisk AS | $3,411.58 | 08/27/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353721 |
| Principal investigator 1 | Novo Nordisk AS | $24.99 | 08/11/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353717 |
| Recipient | Eli Lilly and Company | $355.00 | 07/30/2020 | Covered Recipient Physician | EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) | No dispute reported | 06/30/2026 | 728718107 |
| Principal investigator 1 | Novo Nordisk AS | $6,136.35 | 07/30/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353715 |
| Recipient | Eli Lilly and Company | $1,244.00 | 07/21/2020 | Covered Recipient Physician | A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL COMPARING EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS SEMAGLUTIDE ONCE WEEKLY AS ADD-ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES | No dispute reported | 06/30/2026 | 728717997 |
| Recipient | Eli Lilly and Company | $478.00 | 07/09/2020 | Covered Recipient Physician | A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL COMPARING EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS SEMAGLUTIDE ONCE WEEKLY AS ADD-ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES | No dispute reported | 06/30/2026 | 728716815 |
| Principal investigator 1 | Novo Nordisk AS | $200.00 | 06/25/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353713 |
| Principal investigator 1 | Novo Nordisk AS | $8,136.04 | 06/23/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353711 |
| Principal investigator 1 | JAZZ PHARMACEUTICALS INC. | $825.00 | 06/10/2020 | Non-covered Recipient Entity CLINTRAX GLOBAL INC | BIOANALYSIS OF JZP-110 (SOLRIAMTETOL) IN HUMAN PLASMA BY LC-MS/MS IN SUPPORT OF PROTOCOL JZP188-301 | No dispute reported | 06/30/2026 | 744485273 |
| Principal investigator 1 | Novo Nordisk AS | $11,588.12 | 05/28/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353579 |
| Principal investigator 1 | Novo Nordisk AS | $400.00 | 05/28/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353581 |
| Principal investigator 1 | Eli Lilly and Company | $4,000.00 | 05/11/2020 | Non-covered Recipient Entity COMPASS RESEARCH EAST LLC | A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | No dispute reported | 06/30/2026 | 728737909 |
| Principal investigator 1 | Novo Nordisk AS | $6,062.65 | 04/30/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353577 |
| Principal investigator 1 | Novo Nordisk AS | $75.00 | 04/28/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353585 |
| Principal investigator 1 | Bayer HealthCare Pharmaceuticals Inc. | $1,068.00 | 04/20/2020 | Non-covered Recipient Entity Oviedo Medical Research | Bay1002670 Fibroids Efficacy US / EU | No dispute reported | 06/30/2026 | 713681097 |
| Principal investigator 1 | Boehringer Ingelheim Pharmaceuticals, Inc. | $70.00 | 04/16/2020 | Non-covered Recipient Entity Oviedo Medical Research | COPD pragmatic randomised clinical trial | No dispute reported | 06/30/2026 | 751189745 |
| Principal investigator 1 | Novo Nordisk AS | $49.98 | 04/09/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353587 |
| Principal investigator 1 | Novo Nordisk AS | $4,381.90 | 03/24/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353575 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353589 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353591 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353593 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353595 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353597 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353599 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353601 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353603 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353605 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353607 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353609 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353611 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353613 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353615 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353617 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353619 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353621 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353623 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353625 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353627 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353629 |
| Principal investigator 1 | Novo Nordisk AS | $12.75 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353631 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353633 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353635 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353637 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353639 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353641 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353643 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353645 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353647 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353649 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353651 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353653 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353655 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353657 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353659 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353661 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353663 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353665 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353667 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353669 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353671 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353673 |
| Principal investigator 1 | Novo Nordisk AS | $28.45 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353675 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353677 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353679 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353681 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353683 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353685 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353687 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353689 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353691 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353693 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353695 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353697 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353699 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353701 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353703 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353705 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353707 |
| Principal investigator 1 | Novo Nordisk AS | $16.25 | 03/12/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353709 |
| Principal investigator 1 | Eli Lilly and Company | $427,179.00 | 03/03/2020 | Non-covered Recipient Entity COMPASS RESEARCH EAST LLC | EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) | No dispute reported | 06/30/2026 | 728733923 |
| Principal investigator 1 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4,200.00 | 02/29/2020 | Non-covered Recipient Entity OVIEDO MEDCL RESEARCH, LLC | COPD pragmatic randomised clinical trial | No dispute reported | 06/30/2026 | 751189167 |
| Principal investigator 1 | Novo Nordisk AS | $4,979.28 | 02/27/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353573 |
| Principal investigator 1 | Novo Nordisk AS | $24.99 | 02/25/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353583 |
| Principal investigator 1 | Eli Lilly and Company | $9.57 | 02/20/2020 | Non-covered Recipient Entity COMPASS RESEARCH EAST LLC | A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | No dispute reported | 06/30/2026 | 728743891 |
| Principal investigator 1 | Bayer HealthCare Pharmaceuticals Inc. | $2,000.00 | 02/06/2020 | Non-covered Recipient Entity Oviedo Medical Research | Bay1002670 Fibroids Efficacy US / EU | No dispute reported | 06/30/2026 | 713677069 |
| Principal investigator 1 | Novo Nordisk AS | $5,285.83 | 01/28/2020 | Non-covered Recipient Entity OVIEDO MEDICAL RESEARCH, LLC | EX9536-4388 | No dispute reported | 06/30/2026 | 742353571 |
| Principal investigator 1 | Boehringer Ingelheim Pharmaceuticals, Inc. | $105.00 | 01/17/2020 | Non-covered Recipient Entity OVIEDO MEDCL RESEARCH, LLC | COPD pragmatic randomised clinical trial | No dispute reported | 06/30/2026 | 751189169 |
| Principal investigator 1 | Eli Lilly and Company | $2,764.37 | 01/14/2020 | Non-covered Recipient Entity COMPASS RESEARCH EAST LLC | A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL COMPARING EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS SEMAGLUTIDE ONCE WEEKLY AS ADD-ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES | No dispute reported | 06/30/2026 | 728735871 |
| Principal investigator 1 | Eli Lilly and Company | $147,246.00 | 01/07/2020 | Non-covered Recipient Entity COMPASS RESEARCH EAST LLC | A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL COMPARING EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS SEMAGLUTIDE ONCE WEEKLY AS ADD-ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES | No dispute reported | 06/30/2026 | 728745873 |
| Principal investigator 1 | Eli Lilly and Company | $16,701.26 | 01/03/2020 | Non-covered Recipient Entity COMPASS RESEARCH EAST LLC | EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) | No dispute reported | 06/30/2026 | 728747821 |